Third, though there has been great progress and acceptance recently in the study of blood markers for AD, such as plasma Aβ42/40, neurofilament light chain protein, pTau181, and pTau217, their sensitivity and specificity are still much weaker than that in cerebrospinal fluid. This evidence concerns the gene NEFL and Alzheimer disease.